Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d’ Hebron University Hospital

Authors :: R. Dienstmann
Mafalda Oliveira
Laia Garrigós
Cristina Saura
Marta Capelán
Esther Zamora
B. Rojas
Carolina Ortiz
F. Ruiz-Pace
Santiago Escrivá
Patricia Gomez
Eva Muñoz
Meritxell Bellet
Miriam Arumí
Source :: European Journal of Cancer. 92:S114
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
HER2 negative
University hospital
medicine.disease
chemistry.chemical_compound
Breast cancer
chemistry
Internal medicine
medicine
business
Eribulin

Full Text Access

Tools